|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1999-12-29
|
|
pubmed:abstractText |
Twenty-one patients with Parkinson's disease and psychosis were included in an open-label 8-week trial of olanzapine. Eight subjects had dementia. Six subjects (29%) discontinued treatment prematurely because of drowsiness. Delusions and hallucinations improved significantly, and 80% were rated as much or very much improved. There was no worsening of parkinsonism or cognition.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0895-0172
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
392-4
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:10440017-Aged,
pubmed-meshheading:10440017-Antipsychotic Agents,
pubmed-meshheading:10440017-Benzodiazepines,
pubmed-meshheading:10440017-Dementia,
pubmed-meshheading:10440017-Dose-Response Relationship, Drug,
pubmed-meshheading:10440017-Female,
pubmed-meshheading:10440017-Humans,
pubmed-meshheading:10440017-Male,
pubmed-meshheading:10440017-Neuropsychological Tests,
pubmed-meshheading:10440017-Parkinson Disease,
pubmed-meshheading:10440017-Pirenzepine,
pubmed-meshheading:10440017-Prospective Studies,
pubmed-meshheading:10440017-Psychotic Disorders,
pubmed-meshheading:10440017-Severity of Illness Index,
pubmed-meshheading:10440017-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Olanzapine for psychosis in patients with Parkinson's disease with and without dementia.
|
|
pubmed:affiliation |
Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital, Stavanger, Norway. aarsland@netpower.no
|
|
pubmed:publicationType |
Journal Article
|
